Lawsuit alleges Mylan, other pharma companies conspired to inflate drug prices

Mylan is one of 20 pharmaceutical companies named in a lawsuit by Connecticut Attorney General William Tong, alleging that the manufacturers have conspired to manipulate prices, restrain trade and reduce competition.

According to a press release published by Tong's office on Sunday, Tong is leading a 44-state coalition against the 20 companies, which also includes Teva, Sandoz, and Pfizer. In addition to naming the 20 companies, 15 individual senior executive defendants were singled out, among them Mylan's Vice President of Sales, James Nesta.

You can now customize your WPXI News App to receive alerts to Consumer news.

CLICK HERE to find out how.

The complaint said the companies conspired to fix prices and rig bids for more than 100 different generic drugs. The drugs span all types — from tablets to gels — and treats a range of diseases including cancer, HIV, and epilepsy.

TRENDING NOW:

Pittsburgh Business Times